Creotech S.A.

Creotech Instruments S.A. Gains Approval for Series M Shares on Warsaw Stock Exchange

On June 18, 2026, the Management Board of Creotech Instruments S.A., headquartered in Piaseczno, announced that the Warsaw Stock Exchange (WSE) has approved the admission and introduction of 650,000 Series M ordinary bearer shares to trading on its main market. The shares, identified with the ISIN code PLCRTCH00066, will be registered by the National Depository for Securities (KDPW) and are set to commence trading on June 22, 2026, contingent upon their registration by KDPW by the same date. This development follows the WSE Management Board's Resolution No. 933/2026, issued on June 18, 2026.

Relevance to Creotech S.A.: This milestone reflects Creotech's ongoing efforts to secure capital for its ambitious projects in space technologies, quantum systems, and advanced electronics manufacturing, aligning with its growth strategy and expansion plans in the high-tech sector.

Creotech Instruments: Strategic update — production scale-up, heavier platforms and EU market opportunity

Overview

Creotech Instruments presented a strategic roadmap focused on becoming a leading European prime contractor for complete space systems. Key themes are rapid product-line evolution (from small microsatellites to heavier platforms), a major increase in production and test capacity, targeted European market expansion (ESA and EU programmes), selective capital raises and targeted partnerships / small acquisitions to fill capability gaps.

Key facts and recent results

• Recent performance: 146 million PLN revenue last year and ~38% EBITDA margin on space products; >300 employees.
• Current backlog and pipeline: backlog ≈ 600 million PLN (coverage ~2–2.5 years); sales pipeline ≈ 8 billion PLN.
• Funding plan: proposed issuance of 650,000 new shares (pending approvals) to support expansion.

Product and technology roadmap

• Prime integrator role: Creotech positions itself as a “prime” — designing missions, producing satellites, performing tests, managing launch logistics, operating satellites and delivering ground systems.
• Hypersat platform family: evolution from sub-100 kg platforms (Kestrel, Eagle — both flight-demonstrated) to medium/heavier platforms: Sigal (contracted, flying in 2028 as part of KAMILA), Słon platform (~250 kg, work started Jan — co-funded by PARP) and EMU platform (target ~500 kg with a 2032 readiness goal).
• Modularity advantage: platform evolution relies on largely the same subsystems (computers, avionics, batteries) scaled across classes, reducing development risk.
• Supply-chain positioning: ~97% of subsystems sourced from EU suppliers; company is effectively China‑free and largely ITAR‑free — a European supply‑chain security selling point.

Manufacturing and test capacity expansion

• Current facility: Piaseczno clean-room operational with capacity to produce ~10 satellites/year up to 100 kg.
• Target by 2029: scale production capacity to ~40 satellites/year and enable assembly/test for satellites up to 500 kg (requires larger halls, crane systems and on-site test infrastructure).
• Test internalization: building in‑country test capabilities (now rely on Berlin) to avoid logistic bottlenecks and queueing, essential for high-frequency production.

Market and strategic positioning

• European focus: priority on ESA programmes first, then major post‑2028 EU space and security procurements.
• Addressable opportunity: management highlighted Poland’s increased ESA contribution (substantial georeturn expected) and a large EU programme (cited figure: 131 billion EUR across security/defence/space post‑2028), with an expectation that a meaningful portion will fund small-satellite constellations.
• Target ranking: ambition to become the 4th largest EU prime systems supplier (behind OHB, Airbus Defence & Space, Thales/Leonardo/Alenia group) over the 2030s.
• International expansion and partnerships: opening foreign offices (Toulouse, Germany region and a Kraków office already), pursuing small equity ties / acquisitions (MNEs) to add telecom and space‑heritage capabilities and to serve constellations such as Iris Square in 2028.

Program delivery & risks identified by management

• Prime contracts: Creotech already acts as prime on KAMILA (Sigal satellite) and Microglob (Polish military) projects — multiple 4‑satellite deliveries planned.
• Execution challenges: management acknowledges the need to scale manufacturing and testing quickly to capture ESA and EU programme demand and warned of logistical/test bottlenecks if capacity is not expanded.
• Resourcing & ecosystem: plans rely on growing the supplier ecosystem, hiring engineers (including hiring from EU markets), and securing capital to fund facilities and test equipment.

Immediate near‑term milestones

• Deliver Sigal (part of KAMILA) in 2028 and other contracted satellites for KAMILA and Microglob.
• Begin investments to expand production/test infrastructure (sites already selected; geotechnical work under way).
• Complete expansion of the Hypersat family (Słon and EMU) and plan capacity ramp to ~40 units/yr by 2029.
• Pursue capital issuance and M&A / minority investments to broaden capabilities and secure bids for EU procurements.

Video source: Forum Akcjonariat – Creotech Instruments S.A. | #WallStreet30

Why this matters for Creotech (1–2 sentences): The update outlines concrete steps to scale Creotech from a niche microsatellite maker to a European prime — increased product scope (up to 500 kg), a 4x manufacturing ramp, on‑site testing and targeted access to large ESA/EU funding pools are directly aligned with revenue growth and backlog expansion, but will require the planned funding and successful execution.

Creotech Instruments Transfers Control of PIAST Satellite Constellation to Military University of Technology

On June 16, 2026, Creotech Instruments S.A., a leading Polish high-technology company, announced the successful transfer of management and operational control of the PIAST (Polish Imaging Satellites) constellation to the Faculty of Civil Engineering and Geodesy at the Military University of Technology's "Satellite Operations Center" Laboratory. The PIAST constellation, comprising three satellites—PIAST-M, PIAST-S1, and PIAST-S2—will now be operated through the university's ground segment infrastructure and a Ground Segment as a Service (GsaaS) provider.

The transfer marks a significant milestone in the PIAST project, as it signifies the commencement of nominal operations for the satellite constellation. The mission involves maintaining continuous communication with the satellites, exchanging telemetry and telecommand data, conducting planned experiments, and receiving satellite imagery and other data. This project is the first deployment of Creotech's proprietary HyperSat platform within a satellite constellation.

PIAST is being executed under the leadership of the Military University of Technology, with Creotech as a key consortium partner. The project is funded by Poland's Ministry of National Defense through the National Centre for Research and Development as part of the Szafir program.

Relevance to Creotech S.A.: This milestone underscores Creotech's capabilities in satellite platform development and its strategic role in advancing Poland's space and defense technologies, aligning with its core business focus on space technologies and national defense modernization.

Creotech Instruments S.A. Completes Public Offering of Series M Shares, Raising PLN 481 Million

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, has successfully concluded its public offering of Series M shares. The company announced that a total of 650,000 Series M shares were subscribed at an issue price of PLN 740.00 per share, raising a total of PLN 481 million. The funds have been fully paid by investors as of June 15, 2026.

The Management Board has initiated the process of registering the rights to the Series M shares with the National Securities Depository of Poland (KDPW) and their admission to trading on the Warsaw Stock Exchange. The capital raised will support Creotech's ambitious growth plans, including the development of its proprietary HyperSat satellite platform, quantum communication technologies, and advanced electronics manufacturing capabilities. The offering was coordinated by UniCredit Bank GmbH, Kepler Cheuvreux, J.P. Morgan SE, and Trigon Dom Maklerski S.A., among others.

Relevance to Creotech S.A.: The successful completion of the public offering significantly strengthens Creotech's financial position, enabling the company to further expand its operations in the space and quantum technology sectors, which align with its core business objectives and growth strategy.

Creotech Instruments S.A. Launches Public Offering of Series M Shares to Fund Strategic Growth

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, has announced the commencement of a public offering of up to 650,000 Series M ordinary bearer shares. The offering, conducted through an accelerated bookbuilding process, is targeted at qualified investors and those subscribing for shares worth at least EUR 100,000. The proceeds from the issuance will be allocated to support the company’s 2026-2029 Development Strategy, which includes:

• 40%-60%: Investment in production and R&D infrastructure.
• 20%-30%: Financing research and development, particularly for new satellite platforms and quantum technologies.
• 20%-30%: Funding potential acquisitions, strategic partnerships, international expansion, and operational costs.

The offering is being managed by a consortium of financial institutions, including UniCredit Bank GmbH, J.P. Morgan SE, Trigon Dom Maklerski S.A., and PKO BP. The final number of shares and their issue price will be determined based on the results of the bookbuilding process, which is set to conclude by June 12, 2026. The company has also committed to a 180-day lock-up period, during which it will not issue new shares without prior consent from the offering managers.

The funds raised will enable Creotech to expand its production capabilities, accelerate R&D efforts, and pursue strategic growth opportunities, aligning with its mission to strengthen its position in the space and quantum technology sectors.

Relevance to Creotech S.A.: This public offering is directly tied to Creotech's strategic goals of advancing its satellite and quantum technology platforms, expanding its production infrastructure, and supporting its international growth ambitions.

Creotech Instruments S.A. Announces Key Resolutions from Annual General Meeting

On June 3, 2026, Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies, quantum systems, and advanced electronics manufacturing, held its Annual General Meeting (AGM) in Piaseczno. The meeting resulted in the adoption of several significant resolutions aimed at supporting the company’s strategic growth and operational goals.

Key resolutions included the approval of the company’s financial statements for 2025, which reported a net profit of PLN 13.57 million and an increase in equity by PLN 88.06 million. The AGM also approved the allocation of the entire 2025 net profit to the company’s reserve capital to support future investments and expansion. Additionally, the board members and supervisory board members were granted discharge of their duties for the fiscal year 2025.

One of the most notable resolutions was the decision to increase the company’s share capital by issuing up to 650,000 new Series M shares through a private subscription, with the exclusion of pre-emptive rights for existing shareholders. This move aims to raise funds for the implementation of Creotech’s strategic plan for 2026–2029. The AGM also approved the establishment of a new incentive program for the company’s CEO, Grzegorz Konrad Brona, which includes the issuance of up to 103,600 subscription warrants tied to performance-based milestones.

These resolutions reflect Creotech’s commitment to strengthening its position in the space and quantum technology sectors, as well as its focus on long-term growth and shareholder value.

Relevance to Creotech S.A. Business Profile: The AGM resolutions align with Creotech’s strategic focus on expanding its capabilities in satellite and quantum technologies, leveraging increased European space and defense budgets, and accessing R&D grants to support its growth initiatives.

Creotech Instruments Faces Financial Challenges Amid Strategic Restructuring

Creotech Instruments S.A., a leading Polish high-tech company specializing in space technologies, quantum systems, and advanced electronics manufacturing, reported mixed financial results for Q1 2026. The company recorded a net loss of PLN 6.87 million, a stark contrast to the net profit of PLN 1.4 million in the same period last year. Revenues from continued operations fell to PLN 16.8 million, down from PLN 19.9 million year-on-year, primarily due to project scheduling adjustments. Operating costs surged by PLN 9.7 million, driven by increased employee compensation, social insurance, and subcontractor expenses for key projects such as Mikroglob and CAMILA.

In a significant development, Creotech completed the spin-off of its quantum systems segment into a new entity, Creotech Quantum S.A., in April 2026. The spin-off resulted in the issuance of Creotech Quantum shares to existing shareholders, with the value of the transferred assets significantly exceeding their book value. This transaction is expected to impact the company's financial results in Q2 2026.

Despite the financial setbacks, Creotech achieved several operational milestones, including the successful launch phases of satellites in the PIAST constellation and the acceptance of key milestones in the CAMILA project by the European Space Agency (ESA). The company also initiated a public offering of up to 650,000 new shares to raise approximately EUR 100 million for its 2026-2029 strategic development plan.

Creotech's future performance will depend on securing new ESA contracts, the success of its public offering, and the timely execution of ongoing projects. The company remains optimistic about its growth potential, supported by increased Polish contributions to ESA and the development of the national space industry ecosystem.

Relevance to Creotech S.A.: The article highlights Creotech's financial performance, strategic restructuring, and ongoing projects, which are directly tied to its core business areas of space technologies, quantum systems, and advanced electronics manufacturing.

Creotech Quantum S.A. Reports Financial Losses in Q1 2026 Amid Strategic Developments

Creotech Quantum S.A., a subsidiary of Creotech Instruments S.A., reported a net loss of PLN 44,000 for the first quarter of 2026, reflecting the company's early-stage operational challenges following its spin-off from Creotech Instruments S.A. The company did not generate revenue during the quarter, with operational costs primarily driven by employee wages and social insurance contributions, accounting for 60% of total expenses.

Key developments during the quarter included the signing of a strategic contract with the European Space Agency (ESA) for the "Multi-purpose Quantum Key Distribution receiver for optical ground stations" project. Creotech Quantum will act as a subcontractor to OHB System AG, contributing control electronics and single-photon detectors valued at approximately EUR 300,000. Additionally, the company relocated its operations to a new facility in Warsaw and continued preparations for its independent operations post-spin-off.

Creotech Quantum also successfully completed an IPO, raising PLN 81.2 million through the issuance of 350,000 Series D shares at PLN 232 per share. The funds will be allocated to research and development, infrastructure expansion, and scaling production capabilities.

Despite the financial losses, the company remains optimistic about its growth prospects, citing increased European defense and space budgets, rising demand for quantum communication technologies, and access to EU and Polish R&D grants as positive drivers for future development.

Relevance to Creotech Instruments S.A.: This article highlights the strategic initiatives and financial challenges of Creotech Quantum S.A., a spin-off from Creotech Instruments S.A., showcasing the parent company's expansion into quantum technologies and its alignment with European space and defense priorities.

Creotech Instruments Reports Q1 2026 Financial Results and Strategic Developments

Polish high-tech company Creotech Instruments S.A. has reported total revenues of approximately PLN 27 million for Q1 2026, up from PLN 25.5 million in the same period last year. The company’s backlog for 2026 stood at PLN 254.7 million as of the end of 2025, reflecting strong future commitments. The space projects segment contributed the largest share of revenue, accounting for 71.5% of total sales.

Despite a net loss of PLN 5.4 million in Q1 2026, attributed to increased operational costs and a non-cash motivational program, Creotech maintained a robust financial position with cash reserves of PLN 84 million as of March 2026. The company highlighted that revenue recognition for its major space projects, including Mikroglob and CAMILA, is tied to milestone achievements, which are unevenly distributed across the project timelines.

Additionally, Creotech completed the spin-off of its quantum technology division into a new entity, Creotech Quantum, on April 1, 2026. The fair value of the spun-off segment was estimated at PLN 698.4 million. Creotech Quantum generated PLN 9 million in revenue and a net profit of PLN 1.5 million in Q1 2026.

Looking ahead, Creotech has adopted a new development strategy for 2026–2029, aiming to expand its operations and strengthen its position in the European space market. To support this growth, the company announced a plan to issue up to 650,000 new shares in May 2026 to raise additional capital.

Creotech’s CEO, Grzegorz Brona, emphasized the company’s focus on achieving key milestones in its largest space projects, which are expected to drive revenue growth in the coming quarters. The company also continues to work on projects for the European Space Agency (ESA), the European Commission, and national institutions, ensuring high operational activity.

Relevance to Creotech S.A. Business Profile

This article highlights Creotech’s core activities in space technologies and quantum systems, as well as its strategic focus on expanding its presence in the European space industry. The financial results and project updates underscore the company’s role in delivering advanced satellite and quantum solutions, aligning with its business profile and growth objectives.

Creotech Instruments S.A. Gains Approval for Series D Shares on Warsaw Stock Exchange

Creotech Instruments S.A., a leading Polish high-technology company specializing in space technologies and quantum systems, has announced that the Warsaw Stock Exchange (WSE) has approved the admission and introduction of 350,000 Series D ordinary bearer shares to trading on its main market. The decision, formalized through Resolution No. 759/2026, was made on May 29, 2026. The shares, identified by ISIN code PLCTHQM00034, are set to commence trading on June 3, 2026, contingent upon their registration in the securities depository managed by Krajowy Depozyt Papierów Wartościowych (KDPW) by the same date.

This development marks a significant milestone for Creotech, as the new share issuance is expected to support the company’s ongoing expansion and R&D initiatives in satellite production, quantum communication, and advanced electronics manufacturing.

Relevance: The approval of Series D shares aligns with Creotech’s growth strategy, providing critical funding for its ambitious projects, including the development of its proprietary HyperSat platform and quantum communication technologies.